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We previously identiﬁed gene expression changes in the prefrontal
cortex and hippocampus of rats prenatally exposed to alcohol
under both steady-state and challenge conditions (Lussier et al.,
2015, Alcohol.: Clin. Exp. Res., 39, 251–261). In this study, adult
female rats from three prenatal treatment groups (ad libitum-fed
control, pair-fed, and ethanol-fed) were injected with physiologi-
cal saline solution or complete Freund's adjuvant (CFA) to induce
arthritis (adjuvant-induced arthritis, AA). The prefrontal cortex
and hippocampus were collected 16 days (peak of arthritis) or 39
days (during recovery) following injection, and whole genome
gene expression was assayed using Illumina's RatRef-12 expression
microarray. Here, we provide additional metadata, detailedvier Inc. This is an open access article under the CC BY license
ax: þ1 604 822 2316.
fax: þ1 604 875 3840.
einberg), msk@cmmt.ubc.ca (M.S. Kobor).
A.A. Lussier et al. / Data in Brief 4 (2015) 239–252240explanations of data pre-processing steps and quality control, as
well as a basic framework for the bioinformatic analyses
performed. The datasets from this study are publicly available on
the GEO repository (accession number GSE63561).
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).SpeciﬁcationsOrganism/cell line/
tissueRattus norvegicus – Sprague Dawley (Charles River-derived) – prefrontal cortex and hippocampusSex Female
Sequencer or array
typeIllumina Rat-Ref12 beadarrayData format Raw and quantile normalized
Experimental
factorsPrenatal treatment: control, alcohol, pairfed
Postnatal treatment: saline-injected, adjuvant-injected
Sample collection: day 16 post-injection (peak of arthritis), day 39 post-injection (during recovery)Experimental
featuresAdult female rats from three treatment groups (prenatal alcohol exposed, pair-fed, ad libitum-fed
control) were injected with saline or complete Freund's adjuvant. The prefrontal cortex and
hippocampus of these animals were collected either 16 or 39 days following injection to test the
effects of prenatal alcohol exposure and adjuvant-induced arthritis on gene expression.Consent NA
Sample source
locationVancouver, BC, CanadaKeywords Gene expression, prenatal alcohol, adjuvant, arthritis, ratDirect link to deposited data
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE635611. Experimental design, materials and methods
1.1. Experimental design
Fetal alcohol spectrum disorder (FASD) currently affects 2–5% of children in North America, making
in utero alcohol exposure one of the leading causes of neurodevelopmental disorder [9]. Prenatal
alcohol exposure (PAE) adversely alters the development of the immune system, increasing the
organism's susceptibility to immune and inﬂammatory challenges throughout life. Utilizing an
adjuvant-induced arthritis (AA) paradigm, we have previously shown that PAE increases the course
and severity of arthritis in female rats [14]. However, the molecular mechanisms underlying this
vulnerability are not fully understood. As the prefrontal cortex (PFC) and hippocampus (HPC) are
involved in neuroimmune function, alterations to their gene expression proﬁle could result in
abnormal steady-state functions and response to immune challenges. To test this hypothesis, we
investigated the long-term effects of PAE on gene expression in the adult rat brain, resulting in the
identiﬁcation PAE-speciﬁc changes under both steady-state and challenge conditions [8]. These data
were deposited into the Gene Expression Omnibus (GEO) Series GSE63561, which contains 192 gene
expression microarray samples, and includes both technical replicates and analyzed samples. These
samples were generated from adult female Sprague–Dawley rats from three prenatal treatment
groups: ad libitum-fed control (C), pairfed (PF), and prenatal alcohol exposed (PAE). Animals were
injected with either saline or complete Freund's adjuvant (CFA) to induce arthritis, and terminated at
the peak of inﬂammation or during the recovery phase of arthritis (16 days or 39 days post-injection,
respectively). The prefrontal cortex (PFC) and hippocampus (HPC) were dissected from whole frozen
Fig. 1. Overview of the experimental design prior to sample collection and microarray analysis. Adult female rats from one of
three prenatal treatment groups, control, pair-fed, and prenatal alcohol exposed, were injected with complete Freund's
adjuvant (CFA) to cause adjuvant-induced arthritis (AA). Animals were terminated 16 or 39 days post-injection and microarray
analysis of gene expression was performed on the prefrontal cortex (PFC) and hippocampus (HPC).
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(Fig. 1). In saline-injected animals (steady-state conditions), we identiﬁed changes in gene expression
and altered activation states of upstream regulators speciﬁc to PAE in both brain regions. At the peak
of inﬂammation, we not only uncovered PAE-speciﬁc changes in gene expression, but also a failure of
PAE animals to mount an appropriate response to the inﬂammatory challenge [8].1.2. Breeding and prenatal alcohol exposure
All animal protocols were approved by the University of British Columbia Animal Care
Committee and are consistent with the NIH Guide for the Care and Use of Laboratory
Animals [10]. Complete details of the breeding and handling procedures have been previously
published [3]. Brieﬂy, Sprague Dawley rats were obtained from the Animal Care Center at the
University of British Columbia, and group-housed for 1–2 weeks prior to breeding, with ad libitum
access to standard lab chow (Jamieson's Pet Food Distributors, Ltd., Delta, BC, Canada). Female
and male animals were then co-housed in stainless steel cages with mesh fronts and ﬂoors, with
wax paper under the cages, which was checked daily for the presence of vaginal plugs indicating
gestation day (GD) 1. On GD 1, pregnant dams were singly housed, and assigned to one of three
treatment groups – a control group (C; fed laboratory chow ad libitum), an ethanol-fed group
(prenatal alcohol exposed (PAE); ad libitum access to liquid ethanol diet, with 36% calories derived
from ethanol), or a pair-fed group (PF; liquid control diet, with maltose-dextrin isocalorically
substituted for ethanol, in the amount consumed by an ethanol-consuming partner, matched for
g/kg body weight/day of gestation). Experimental diets were administered from GD 1–21 (Weinberg/
Kiever Ethanol Diet 710324, Weinberg/Kiever Control Diet 710109, Dyets Inc., Bethlehem, PA),
and all animals had ad libitum access to water. On GD 21, experimental diets were replaced with
standard laboratory chow. At birth, litters were weighed and culled to 5 males and 5 females, when
possible. Following weaning on postnatal day 22, female offspring were group-housed by litter (2–3
rats per cage) until testing. Blood alcohol levels for dams in this paradigm usually average 120–
150 mg/dl [12,5].
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In adulthood (55–65 days of age), female offspring from C, PF, and PAE prenatal groups were
selected for the study; females were tested due to their increased susceptibility to arthritis [13]. CFA
was prepared by grinding powdered Mycobacterium tuberculosis H37 Ra (Difco laboratory, Detroit,
MI) using a mortar and pestle, and dissolving it in 1 mL of mineral oil (Difco laboratory, Detroit, MI).
Animals in the adjuvant group were given a 100 mL intradermal injection of a 12 mg/mL CFA
suspension at the base of tail to induce arthritis (AA). In parallel, animals in the saline control group
were given a 100 mL intradermal injection of a saline solution (0.9%) at the base of tail. Following
injection, all animals were singly housed and monitored for clinical signs of arthritis. On post-
injection days 7, 10, and every other day thereafter, animals were lightly anesthetized with isoﬂuorane
and clinical scores were assigned based on severity of paw redness and swelling (Supplementary
information; results previously published in [14]).1.4. Termination of animals
Two cohorts of C, PF, and PAE females were run in overlapping subsets for the analysis of gene
expression in order to capture gene expression changes associated with the progression of AA. The
ﬁrst cohort was terminated 16 days post-injection, at the peak of arthritis, and the second was
terminated 39 days post-injection, during the resolution phase of arthritis. Each cohort contained 27
adjuvant-injected (n¼9 per prenatal treatment group) and 15–18 saline-injected animals (n¼5–6 per
prenatal treatment group). At termination, animals were removed one by one from the colony room,
exposed to carbon dioxide for 30 seconds, and quickly decapitated. Brains were rapidly removed,
snap-frozen on dry ice, and stored at 80 1C.1.5. Tissue dissection and RNA extraction
The prefrontal cortex (PFC) and hippocampus (HPC) were dissected using RNase-free technique on
brains pre-thawed at 20 1C for 30 min and then thawed on ice for 20 min. Dissected tissues were
placed in chilled RNAlater and stored at 20 1C until RNA extraction. Of note, tissues were dissected
in three batches, which ranged from December 2007 to May 2010 (Supplementary information). RNA
and DNA were simultaneously extracted from samples using Qiagen's All-Prep DNA/RNA Mini kit
(QIAGEN Inc., Toronto, ON). Brain tissue was placed in lysis buffer and disrupted using a 20 G needle,
followed by a round of mechanical sheering using a 23 G needle, and a ﬁnal homogenization by
QIAshredder columns (QIAGEN Inc., Toronto, ON). RNA and DNA were then extracted from lysates
according to the manufacturer's instructions and the DNase digestion step was included in the process
to remove DNA contamination that might confound gene expression data. One hippocampus from a
PF female in the adjuvant-treated group terminated on day 39 was excluded at this stage due to
contamination during RNA extraction. Samples were extracted in two batches, either in the fall of
2009 or summer of 2010.
RNA integrity numbers (RIN) were assayed using the Agilent BioAnalyzer mRNA Nano assay and no
samples were excluded due to low RNA quality. The mean RIN was above 9 for both the PFC and HPC
and there were no signiﬁcant differences between tissues (Fig. 2A). The HPC showed more variability
in the quality of RNA and a single sample skewed the distribution of this tissue, but remained above
the minimal value of 6 (Supplementary Table 2). Certain samples from the HPC also produced
intensities too low to accurately measure RIN, marked as NA, but were not excluded as they appeared
of good quality upon visual inspection of the raw Bioanalyzer peaks (Supplementary information).
Signiﬁcant differences in RIN between extraction and dissection rounds were also observed in both
tissues (Fig. 2B and C; po1e5, Welch's t-test), which were potentially due to slight procedural
differences between the individuals performing these steps and/or longer storage of the ﬁrst batch as
dissected tissue prior to RNA extraction.
Fig. 2. RNA integrity numbers (RIN) differ between extraction and dissection rounds. (A) No difference in average RIN was
identiﬁed between samples from the prefrontal cortex (PFC) and the hippocampus (HPC). (B) Signiﬁcant effects of tissue
dissection round were identiﬁed between round 1 and round 3 in both tissues. Dissection round 2 contained a single sample in
both tissues and was not included in statistical analysis. (C) Signiﬁcant effects of RNA extraction round were also observed in
both tissues. nDenotes statistical signiﬁcance below po0.00001 by Welch's t-test.
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Total RNA (250 ng) was ampliﬁed into cRNA in batches of 24 samples using the Ambion Illumina
TotalPrep RNA Ampliﬁcation kit (Life Technologies, Carlsbad, CA). Samples were randomly distributed
across ampliﬁcation cohorts to avoid confounding batches with experimental treatment groups
(Supplementary information). One ampliﬁcation replicate was included in the PFC set of samples to
assay for reproducibility between ampliﬁcation rounds. Expression data were obtained using the
Illumina RatRef-12 Expression BeadChip microarray, which contains 12 arrays per chip and provides
probe-level data for all expressed genes in the rat genome (1 probe per gene). In concordance with
the manufacturer's recommendations, 750 ng of cRNA from a single sample was hybridized to each
array, and arrays were scanned on the Illumina iScan to obtain raw bead-level expression data.
Experimental groups were counter-balanced across chips, such that chip batch was not confounded
with experimental groups, as well as dissection, extraction, or ampliﬁcation batch (Supplementary
information). A total of 96 arrays were run for each tissue. In addition to the 87 experimental samples,
PFC arrays also included 1 ampliﬁcation replicate and 8 hybridization replicates. HPC arrays consisted
of 84 experimental samples, as well as 12 hybridization replicates. Hybridization replicates in the PFC
dataset originated from a single sample, while those in the HPC dataset originated from 4 different
samples. Arrays for each tissue were run separately on different days, due to a processing limit of
8 chips, or 96 arrays. Of note, PFC samples were ampliﬁed in August 2010 and run in September 2010,
while HPC samples were ampliﬁed in December 2010 and run in January 2011.
1.7. Data pre-processing and quality control
Datasets from both tissues were processed and analyzed separately throughout the entire study, as
performing a comparison among prenatal treatment groups was more important than a direct
comparison between tissues. Following the acquisition of raw expression data for each array, spatial
artifacts were identiﬁed using the BASH algorithm [1] and masked prior to calculating the
summarized expression values for each probe. The bioconductor package beadarray [2] was then
used to collapse raw bead-level data into probe-level data, which was log 2-transformed for
downstream applications.
Datasets were quantile-normalized in the beadarray package and pairwise Pearson correlations
were calculated to compare expression proﬁle correlations (Table 1). Hybridization replicates for both
the PFC and HPC were highly correlated (40.94), as were the ampliﬁcation replicates in the PFC
(40.98) (Fig. 3), suggesting that microarray assays were carried out reproducibly. Although most
samples within the same tissue were very highly correlated (Fig. 4), two samples from the PFC were
Table 1
Quantile distributions of pairwise Pearson correlations of arrays from the prefrontal cortex (PFC) and hippocampus (HPC).
Tissue Group n 0% 25% 50% 75% 100%
PFC All samples 96 0.897 0.966 0.971 0.976 1.000
Technical replicates 11 0.956 0.972 0.978 0.982 1.000
Ampliﬁcation replicates 2 0.980 0.980 0.990 1.000 1.000
Hybridization replicates 9 0.957 0.971 0.979 0.982 1.000
Samples only – no outliers 85 0.944 0.968 0.972 0.977 1.000
HPC All samples 96 0.925 0.956 0.965 0.971 1.000
Hybridization replicates 16 0.936 0.958 0.966 0.973 1.000
Hybridization Group 1 4 0.961 0.968 0.971 0.982 1.000
Hybridization Group 2 4 0.971 0.972 0.986 0.990 1.000
Hybridization Group 3 4 0.964 0.969 0.974 0.984 1.000
Hybridization Group 4 4 0.957 0.963 0.980 0.989 1.000
Samples only – no outliers 84 0.924 0.958 0.967 0.972 1.000
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counterparts (Fig. 4A). These arrays, 5398636033_K and 5398636033_L, corresponded to a PAE
sample from the day 39 saline group and a C sample from the day 39 adjuvant group respectively and
contained large spatial artifacts. While outlier beads were masked during preprocessing and omitted
when calculating expression levels, these extensive artifacts likely contributed to the observed
discrepancy in sample correlation. As such, these two samples were removed from subsequent
analyses. No samples were ﬂagged as outliers in the HPC dataset (Fig. 4B), as all arrays showed
correlation values 40.92.
Outliers and technical replicates were removed from the datasets for gene expression analyses. The
ﬁnal dataset for each tissue consisted of 85 samples in the PFC and 84 samples in the HPC (Table 2).
The original probe-level expression data, prior to quantile normalization, was ﬁltered to remove
control probes and those with a detection p-value 40.05 compared to negative controls. After
ﬁltering, 20,215 probes remained in the PFC dataset, and 20,069 probes remained in the HPC dataset,
from a total 23,350 probes. The ﬁltered, log 2-transformed gene expression proﬁles were then
quantile-normalized across arrays within each tissue. No samples stood out as outliers at this stage, as
per Pearson correlations (Fig. 5).2. Data analysis summary
2.1. Exploratory data analysis
Upon visual examination of sample clustering in the heatmaps, the samples of the PFC and HPC
showed a slight tendency to cluster by adjuvant exposure and stage of arthritis (day 16, peak of
inﬂammation, or day 39, recovery phase), but not by prenatal treatment (Fig. 5). However, sample
clustering also partially reﬂected batch effects from the different extraction, dissection, and ampliﬁcation
rounds, as well as variation between chips (data not shown). Thus, principal component analysis (PCA)
was used to further investigate the expression heterogeneity caused by these external covariates (Fig. 6).
In order to visualize more subtle variationwithin the data, the ﬁrst principal component was omitted, as it
did not correlate with any metadata variables and represented a very large proportion of the variance,
masking other signiﬁcant effects. The remaining components were adjusted based on the variance of the
ﬁrst principal component and analyzed to identify associations with different metadata variables and
obtain a visual representation of variation sources within the datasets.
In the PFC, the majority of variation was correlated with batch effects from the different dissection,
extraction, and ampliﬁcation rounds, as well as chip-speciﬁc effects (Fig. 6A). RIN values also appeared
to play a signiﬁcant role in sample variation, but this effect may be confounded by the signiﬁcant
differences between dissection and extraction rounds (Fig. 2). Slight effects of experimental
treatments, such as stage of arthritis (day 16 or 39), adjuvant exposure, and prenatal treatment,
Fig. 3. Technical replicates were highly correlated within the prefrontal cortex (PFC) and hippocampus (HPC). Quantile
normalized hybridization and ampliﬁcation replicates were compared by pairwise Pearson correlation and clustered according
to inter-sample correlation values. (A) In the PFC, all hybridization replicates (Hyb_rep), consisting of 9 arrays from the same
original sample, were highly correlated, with correlation values 40.95. The ampliﬁcation replicates (Amp_rep), consisting of
2 arrays from the same sample, were also highly correlated and clustered together. (B) In the HPC, all hybridization replicates,
which originated from 4 different samples (group), were highly correlated, with correlation values 40.94, and partially
clustered by original sample group. Unique array identiﬁcation numbers are displayed on the right side of each heatmap.
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Fig. 4. Most arrays were highly correlated within the prefrontal cortex (PFC) and hippocampus (HPC). Quantile normalized
arrays were compared by pairwise Pearson correlation and clustered according to inter-sample correlation values. (A) In the
PFC, most arrays were highly correlated, with correlation values 40.94. Two samples were identiﬁed as outliers, due to their
separate clustering and apparent discordance with other arrays. (B) In the HPC, arrays were highly correlated, with correlation
values 40.92, and no samples clustered individually. Samples in either tissue did not cluster by termination day (Day),
adjuvant exposure (Adjuvant), prenatal treatment (Treatment), or sample type (Type).
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Table 2
Distribution of sample numbers between different prenatal treatments, termination days, and adjuvant-induced arthritis (AA)
treatments for the prefrontal cortex (PFC) and hippocampus (HPC).
Prenatal treatment Termination day AA treatment PFC HPC
Control Day 16 Saline 5 5
Adjuvant 9 9
Day 39 Saline 6 6
Adjuvant 8 8
Pair-fed Day 16 Saline 5 5
Adjuvant 9 9
Day 39 Saline 6 6
Adjuvant 9 7
Prenatal alcohol exposure Day 16 Saline 5 5
Adjuvant 9 9
Day 39 Saline 5 6
Adjuvant 9 9
Total 85 84
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of arthritis and clinical score, which is closely related to the response to adjuvant treatment. However,
the low proportion of the variance represented by experimental treatments suggests that their effects
on gene expression are subtle, which was taken into consideration in downstream analyses.
By contrast, considerably fewer batch effects were observed in the HPC than in the PFC, as only
batches of animals terminated together (set) and extraction round were correlated with the ﬁrst ﬁve
principal components. This may have been due to improved technique during RNA extraction, as HPC
samples were processed after the PFC samples, or more consistent HPC dissections thanks to its more
distinct anatomical landmarks, which resulted in less technical and biological variability. Moreover,
signiﬁcant effects of stage of arthritis (day 16 or 39) and adjuvant treatment, including the related
clinical score, were present in the HPC dataset, suggesting that this region is more susceptible to the
effects of adjuvant on gene expression than the PFC. No effects of prenatal treatment were apparent in
this exploratory analysis of hippocampal gene expression.
Of note, termination of animals in this study occurred over several months due to the large number
of animals, frequent monitoring throughout AA, and extensive processing involved at termination.
While animals terminated together (sets) were counterbalanced for prenatal group and adjuvant
treatment, they were not counterbalanced for stage of arthritis (day 16 or 39), and more adjuvant-
injected (n¼9 per prenatal treatment group) than saline-injected (n¼5–6 per prenatal treatment
group) animals were present in each cohort. As such, it is not completely unexpected that some
variability in the data is associated with set. However, as animals were terminated in overlapping
cohorts based on stage of arthritis, the effects of set observed by PCA were potentially confounded
with termination day (i.e. peak of inﬂammation or recovery phase), or adjuvant treatment, which are
also present in the ﬁrst principal components. Furthermore, a large number of principal components
did not correlate with any metadata variables in both tissues. These uncorrelated components may
represent variation within the data caused by unknown factors, such as inter-individual differences
and cell type composition, which could play a role in gene expression differences between groups.2.2. Differential expression analysis
In order to correct for these unknown variables, as well as signiﬁcant batch effects in the two
datasets, surrogate variable analysis (sva) was used to generate variables representative of expression
heterogeneity within the two datasets [7]. This method identiﬁes eigenvectors of variation not
associated with primary variables, which can then be incorporated as covariates during linear
modeling to remove unwanted sources of heterogeneity. These surrogate variables were generated
Fig. 5. Filtered and quantile normalized samples were highly correlated in the prefrontal cortex (PFC) and hippocampus (HPC).
Arrays were ﬁltered to remove control and low-quality probes, then quantile normalized prior to pairwise Pearson correlation
and clustering according to inter-sample correlation values. (A) In the PFC, all samples were highly correlated, with values
40.95. Samples partially clustered by termination day (Day) and adjuvant exposure (Adjuvant), but did not reﬂect any effect of
prenatal treatment (Treatment). (B) In the HPC, all samples were also highly correlated, with values 40.95. Samples partially
clustered by termination day and adjuvant exposure, but did not cluster by prenatal treatment.
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Fig. 6. Principal component analysis of normalized and ﬁltered datasets from the prefrontal cortex (PFC) and hippocampus
(HPC) identiﬁed signiﬁcant batch effects. Adjusted principal components (PC) were analyzed to identify associations with
metadata variables and visualize signiﬁcant sources of variation within the data. (A) In the PFC, batch effects, such dissection,
extraction, and ampliﬁcation round, as well as inter-chip variation, and RNA integrity numbers (RIN) accounted for a large
proportion of the adjusted variance. Treatment effects, such as termination day (Day), adjuvant treatment (Adjuvant), total
clinical score (Clinical Score), and prenatal treatment (Treatment) accounted for some variance in later principal components.
(B) In the HPC, effects from the experimental batch (Set) and extraction round were identiﬁed in the ﬁrst principal components.
Effects of termination day, adjuvant exposure, and total clinical score also accounted for a signiﬁcant proportion of the variance.
A.A. Lussier et al. / Data in Brief 4 (2015) 239–252 249
Table 3
Total number of variables identiﬁed by surrogate variable analysis between steady-state and saline versus adjuvant in the
prefrontal cortex (PFC) and hippocampus (HPC).
Analysis Termination day PFC HPC
Steady-state (prenatal treatment) Day 16 6 2
Day 39 4 6
Saline versus adjuvant (prenatal treatment n adjuvant exposure) Day 16 15 8
Day 39 11 12
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analyzed in two different ways, consistent with later bioinformatic analyses of gene expression
changes (Table 3, Simpliﬁed_Rscript). In the ﬁrst analysis, prenatal treatment was selected as the sole
primary variable in order to test for steady-state gene expression in saline-injected animals. In the
second analysis, prenatal treatment and adjuvant treatment were selected as primary variables in
order to test differences in response to an inﬂammatory challenge compared to the response to saline
in animals from the three prenatal treatment groups.
Surrogate variables generated by sva were included as covariates in linear modeling of gene
expression using the limma package in the statistical program R [11]. Just as in surrogate variable
analysis, gene expression changes were modeled in two different ways, with animals from day 16 and
39 separate from each other. First, the effects of prenatal treatment alone in saline-injected animals
were analyzed to identify gene expression speciﬁc to the steady-state condition. Second, the
interaction of prenatal treatment and adjuvant exposure in saline- versus adjuvant-injected animals
was analyzed to identify differential responses to adjuvant exposure in each prenatal treatment group.
Cohorts of saline-injected PAE, PF, and C females were terminated in parallel with adjuvant-injected
animals on days 16 and 39 post-injection. In all models, a moderated F-statistic was generated for
each probe, which adjusted for multiple testing using Benjamini–Hochberg correction. As the effects
of experimental treatments were subtle, the false-discovery rate (FDR) was controlled at 25% (q-value
o0.25). Within probes below this cutoff, those with a p-value o0.05 in contrasts of interest were
considered signiﬁcant.
To identify PAE-speciﬁc changes in expression under steady-state conditions, genes were required
to display differential expression in both PAE versus C and PAE versus PF contrasts, while showing no
difference between PF and C animals (p40.05). On day 16 post-injection, 15 differentially expressed
probes speciﬁc to PAE animals were identiﬁed in the PFC, while 4 were identiﬁed in the HPC [8]. No
signiﬁcant changes were identiﬁed between prenatal treatment groups on day 39 post-injection. This
absence of group effects may be due to greater intra-group variability caused by the frequent handling
over the paradigm's 39 day period, or adaptation of the animals to the handling procedures. As such,
the day 39 group was not included in the subsequent analyses.
To identify the speciﬁc response of PAE animals to adjuvant, gene expression differences were
analyzed in two steps. First, gene expression differences between saline- and adjuvant-injected
animals of the same prenatal treatment group were obtained. Next, lists of signiﬁcant genes were
contrasted to obtain those altered in PAE versus C and PF, while showing no difference between C and
PF. In addition, signiﬁcant gene expression changes in saline- versus adjuvant-treated animals present
in both control groups, but absent in PAE animal were also considered unique PAE responses. On Day
16 post-injection, 8 probes in the PFC and 4 in the HPC were differentially expressed in PAE compared
to PF and C animals, while all groups showed a global up-regulation of mRNA levels [8]. Please refer to
the attached Simpliﬁed_Rscript for an abridged version of these analyses.
As the majority of probes on the RatRef-12 beadchip were designed based on transcripts in RefSeq
with only provisional annotation, the sequences for signiﬁcant probes were queried against the most
recent RefSeq database for Rattus norvegicus to establish the identity of target transcripts. Gene
Ontology was performed on all genes using the gene-score resampling method in ermineJ [6], and
Ingenuity© Upstream Regulator Analysis (URA, Ingenuity Systems Inc., Redwood City, CA) was
performed on genes with a fold change Z1.2 and p-valueo0.05 between treatments in order to
identify effects of PAE and adjuvant injection on the transcriptome [8].
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The exploratory portion of our analysis stresses the importance of consistent procedures, as well as
balanced groups during all phases of studies requiring staggered experiments with large group sizes.
Balanced experiments could mitigate the impact of confounding factors, facilitating their removal
through bioinformatic methods such as ComBat [4], or by including them as covariates during linear
modeling. Importantly, in the present study, despite some increase in variability due to the necessity
to run cohorts in overlapping sets, signiﬁcant effects of prenatal treatment were observed, suggesting
relatively robust effects of prenatal alcohol exposure on steady-state functions and the response to an
inﬂammatory challenge.
3.1. GEO submission
Probe-level data for this study were deposited on the GEO (GSE63561), along with metadata
describing experimental treatment groups. As described, spatial artifacts were masked from the
dataset and data were log 2-transformed prior to submission of raw and quantile-normalized data.
Moreover, due to GEO submission requirements, the datasets were ﬁltered to include only probes
associated with a gene. As such, the current GEO ﬁles do not contain any control probes, although
these additional data are available upon request.Acknowledgments
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